FindTrial
Sign In

Clinical study on Zhou's Qiling Decoction inducing apoptosis of prostate cancer cells through miR-143 / Bcl-2 pathway

Clinical study on Zhou's Qiling Decoction inducing apoptosis of prostate cancer cells through miR-143 / Bcl-2 pathway

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039072
Enrollment
Unknown
Registered
2020-10-15
Start date
2020-10-20
Completion date
Unknown
Last updated
2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Intervention:Zhoushi Qiling decoction
Placebo:No Zhoushi Qiling decoction

Sponsors

Surgical Department I (Urology Department), Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with prostate cancer; 2. Patients with complete medical records; 3. Patients aged 50-75 years; 4. Patients with prognosis more than 4 months.

Exclusion criteria

Exclusion criteria: Patients who have received radiotherapy or chemotherapy.

Design outcomes

Primary

MeasureTime frame
Survival time;—

Countries

China

Contacts

Public ContactLei Chen

Department of Urology I, Longhua Hospital, Shanghai University of Traditional Chinese Medicine

chenleijoe@126.com+86 13003255716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026